Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms. Tibes R, Kosiorek HE, Dueck AC, Palmer J, et al. Cancer 2023;129:2321-2330.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tibes R, Kosiorek HE, Dueck AC, Palmer J, et al. Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms. Cancer 2023;129:2321-2330.
PMID: 37042080